when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked · 322 matching

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health

Marketed
alitretinoin
Panretin (alitretinoin)
Kaposi Sarcoma Galephar Pharmaceutical Research Inc5 cat
Marketed
capivasertib
Truqap (capivasertib)
Human Epidermal Growth Factor Receptor 2 Negative Breast…$AZN ASTRAZENECA PLC5 cat
Marketed
epcoritamab
Epkinly (epcoritamab-bsyp)
Diffuse Large B-Cell Lymphoma Genmab AS5 cat
Marketed

page 3 of 11

131

loncastuximab tesirine

Zynlonta (loncastuximab tesirine-lpyl)

Diffuse Large B-Cell Lymphoma

$ADCT ADC Therapeutics SA

5 cat

Marketed

Poteligeo (mogamulizumab)

Peripheral T-Cell Lymphomas (PTCL) Kyowa Kirin Co Ltd5 cat

Marketed

Zejula (niraparib)

Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON5 cat

Marketed

Hormone Sensitive Breast Cancer Eagle Pharmaceuticals Inc4 cat

Marketed

Germinomatous (Seminomatous) Germ Cell Tumors Baxter Healthcare Corp4 cat

Marketed

Colon Cancer Ingenus Pharmaceuticals LLC4 cat

Marketed

lutetium Lu 177 vipivotide tetraxetan

Pluvicto (lutetium Lu 177 vipivotide tetraxetan)

Hormone-Sensitive Prostate Cancer$NVS NOVARTIS AG4 cat

Marketed

momelotinib dihydrochloride

Ojjaara (momelotinib dihydrochloride)

Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) GlaxoSmithKline LLC4 cat

Marketed

polatuzumab vedotin

Polivy (polatuzumab vedotin-piiq)

Diffuse Large B-Cell Lymphoma Genentech Inc4 cat

Marketed

Orgovyx (relugolix)

Prostate Cancer Sumitomo Pharma America Inc4 cat

Marketed

tisotumab vedotin

Tivdak (tisotumab vedotin-tftv)

Bladder Cancer Genmab AS4 cat

Marketed

ANAGRELIDE HYDROCHLORIDE

ANAGRELIDE HYDROCHLORIDE

Thrombosis Takeda Pharmaceuticals USA Inc3 cat

Marketed

Alimta (pemetrexed disodium)

Malignant Pleural Mesothelioma Lilly USA LLC3 cat

Marketed

Adrenal Insufficiency$ETON Eton Pharmaceuticals, Inc.3 cat

Marketed

GEMCITABINE HYDROCHLORIDE

GEMCITABINE HYDROCHLORIDE

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$JNJ JOHNSON & JOHNSON3 cat

Marketed

Colon Cancer Armas Pharmaceuticals Inc3 cat

Marketed

cyclophosphamide

Cyclophosphamide (cyclophosphamide [INN])

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Long Grove Pharmaceuticals LLC3 cat

Marketed

ensartinib hydrochloride

Ensacove (ensartinib hydrochloride)

Non-Small Cell Lung Cancer Xcovery Holdings Inc3 cat

Marketed

Lytgobi (futibatinib)

Bile Duct Cancer (Cholangiocarcinoma) Taiho Oncology Inc3 cat

Marketed

Columvi (glofitamab-gxbm)

Mantle Cell Lymphoma F. Hoffmann-La Roche Ltd3 cat

Marketed

Itovebi (inavolisib)

Human Epidermal Growth Factor Receptor 2 Positive Breast… F. Hoffmann-La Roche Ltd3 cat

Marketed

lazertinib mesylate

Lazcluze (lazertinib mesylate)

Non-Small Cell Lung Cancer$JNJ JOHNSON & JOHNSON3 cat

Marketed

Lunsumio Velo (mosunetuzumab-axgb)

Diffuse Large B-Cell Lymphoma Genentech Inc3 cat

Marketed

quizartinib dihydrochloride

Vanflyta (quizartinib dihydrochloride)

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Daiichi Sankyo Co Ltd3 cat

Marketed

(abiraterone acetate + niraparib)

Akeega ((abiraterone acetate + niraparib))

Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON2 cat

Marketed

(amivantamab + hyaluronidase (human recombinant))

Rybrevant Faspro ((amivantamab + hyaluronidase-rhu (human recombinant)))

Recurrent Head And Neck Squamous Cell Carcinoma$JNJ JOHNSON & JOHNSON2 cat

Marketed

Carboplatin Pfizer

Metastatic Ovarian Cancer$PFE PFIZER INC2 cat